SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2p24'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MCN_P_DHIP1_0 (IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) PEPTIDE N-ACETYL-D-HIS-L-PRO -NH2)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus)	3 / 3	PHE B 111 TYR B 126 PRO B 113	None	0.99A	1mcnA-2p24B: 13.4 1mcnB-2p24B: 13.2 1mcnP-2p24B: undetectable	1mcnA-2p24B: 25.66 1mcnB-2p24B: 25.66 1mcnP-2p24B: 0.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P6K_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus; Mus musculus)	4 / 8	SER A 144 ARG B 134 GLN A 88 ASP A 110	None	1.17A	1p6kB-2p24A: undetectable	1p6kB-2p24A: 22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RS6_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus; Mus musculus)	4 / 8	SER A 144 ARG B 134 GLN A 88 ASP A 110	None	1.13A	1rs6B-2p24A: undetectable	1rs6B-2p24A: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZQ_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus; Mus musculus)	4 / 8	SER A 144 ARG B 134 GLN A 88 ASP A 110	None	1.16A	1zzqB-2p24A: undetectable	1zzqB-2p24A: 22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus; Mus musculus)	4 / 8	SER A 144 ARG B 134 GLN A 88 ASP A 110	None	1.11A	1zzuA-2p24A: undetectable	1zzuA-2p24A: 22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus; Mus musculus)	4 / 8	SER A 144 ARG B 134 GLN A 88 ASP A 110	None	1.16A	1zzuB-2p24A: undetectable	1zzuB-2p24A: 22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A27_A_SAMA250_1 (UNCHARACTERIZED PROTEIN MJ1557)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN (Mus musculus)	3 / 3	MET A 44 GLU A 25 ASN A 140	None	0.98A	3a27A-2p24A: undetectable	3a27A-2p24A: 21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N62_B_MTLB870_0 (NITRIC OXIDE SYNTHASE)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus; Mus musculus)	4 / 8	SER A 144 ARG B 134 GLN A 88 ASP A 110	None	1.15A	3n62B-2p24A: undetectable	3n62B-2p24A: 22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B53_B_ACTB1445_0 (IG GAMMA-4 CHAIN C REGION)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN (Mus musculus)	3 / 3	GLU A 25 GLY A 28 SER A 8	None	0.44A	4b53B-2p24A: 15.4	4b53B-2p24A: 17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DX7_B_DM2B1104_1 (ACRIFLAVINE RESISTANCE PROTEIN B)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN (Mus musculus)	4 / 8	GLN A 21 GLU A 25 ILE A 119 VAL A 165	None	0.98A	4dx7B-2p24A: undetectable	4dx7B-2p24A: 14.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F8Y_B_VK3B202_1 (NADPH QUINONE OXIDOREDUCTASE)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus)	4 / 6	ASN A 69 TYR B 147 TYR B 161 LEU B 138	None	1.39A	4f8yA-2p24A: undetectable 4f8yB-2p24A: undetectable	4f8yA-2p24A: 21.57 4f8yB-2p24A: 21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGL_C_CLQC303_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN (Mus musculus)	4 / 8	GLY A 7 VAL A 6 HIS A 5 PHE A 48	None	0.82A	4fglD-2p24A: undetectable	4fglD-2p24A: 24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J4V_D_SVRD301_1 (NUCLEOCAPSID PROTEIN)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus)	5 / 11	GLY A 169 ASN A 84 ARG B 134 ALA A 82 ILE A 117	None	1.29A	4j4vD-2p24A: undetectable 4j4vE-2p24A: undetectable	4j4vD-2p24A: 22.58 4j4vE-2p24A: 22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MWR_A_ZMRA513_2 (NEURAMINIDASE)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus)	4 / 5	LEU B 175 ASP B 141 ARG B 125 ILE A 1	None	1.40A	4mwrA-2p24B: undetectable	4mwrA-2p24B: 20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YV5_A_SVRA205_1 (BASIC PHOSPHOLIPASE A2 HOMOLOG 2)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN (Mus musculus)	4 / 7	ASN A 118 TYR A 150 LEU A 151 PHE A 153	None	1.25A	4yv5A-2p24A: undetectable	4yv5A-2p24A: 17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YV5_B_SVRB207_2 (BASIC PHOSPHOLIPASE A2 HOMOLOG 2)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN (Mus musculus)	4 / 7	ASN A 118 TYR A 150 LEU A 151 PHE A 153	None	1.24A	4yv5B-2p24A: undetectable	4yv5B-2p24A: 17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A06_B_SORB1342_0 (ALDOSE-ALDOSE OXIDOREDUCTASE)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN (Mus musculus)	4 / 7	ILE A 63 LEU A 60 GLY A 58 GLY A 59	None	0.85A	5a06B-2p24A: undetectable	5a06B-2p24A: 20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A06_F_SORF1341_0 (ALDOSE-ALDOSE OXIDOREDUCTASE)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN (Mus musculus)	4 / 7	ILE A 63 LEU A 60 GLY A 58 GLY A 59	None	0.86A	5a06F-2p24A: undetectable	5a06F-2p24A: 20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DV4_A_NMYA601_2 (CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus)	3 / 3	GLU B 287 TRP B 288 ASN B 234	None	1.05A	5dv4A-2p24B: undetectable	5dv4A-2p24B: 20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FSA_B_X2NB590_1 (CYP51 VARIANT1)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus)	5 / 12	GLY B 1 TYR A 133 PHE A 138 ILE A 106 GLY B 251	None	1.29A	5fsaB-2p24B: undetectable	5fsaB-2p24B: 19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W3J_B_TA1B502_1 (TUBULIN BETA CHAIN)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus)	4 / 8	VAL A 72 HIS B 10 GLY B 154 LEU B 138	None	0.93A	5w3jB-2p24A: undetectable	5w3jB-2p24A: 20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YOD_F_BEZF201_0 (NS3 PROTEASE)	2p24	H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN (Mus musculus)	4 / 5	ALA B 9 SER B 8 TYR B 167 TYR B 160	None	1.44A	5yodF-2p24B: undetectable	5yodF-2p24B: 21.48

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1MCN_P_DHIP1_0","IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN);PEPTIDE N-ACETYL-D-HIS-L-PRO-NH2","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus",3,"PHE B 111;TYR B 126;PRO B 113","None","0.99A","1mcnA-2p24B:13.4;1mcnB-2p24B:13.2;1mcnP-2p24B:undetectable","1mcnA-2p24B:25.66;1mcnB-2p24B:25.66;1mcnP-2p24B:0.87"],["1P6K_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus;Mus musculus",4,"SER A 144;ARG B 134;GLN A  88;ASP A 110","None","1.17A","1p6kB-2p24A:undetectable","1p6kB-2p24A:22.41"],["1RS6_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus;Mus musculus",4,"SER A 144;ARG B 134;GLN A  88;ASP A 110","None","1.13A","1rs6B-2p24A:undetectable","1rs6B-2p24A:22.17"],["1ZZQ_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus;Mus musculus",4,"SER A 144;ARG B 134;GLN A  88;ASP A 110","None","1.16A","1zzqB-2p24A:undetectable","1zzqB-2p24A:22.00"],["1ZZU_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus;Mus musculus",4,"SER A 144;ARG B 134;GLN A  88;ASP A 110","None","1.11A","1zzuA-2p24A:undetectable","1zzuA-2p24A:22.00"],["1ZZU_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus;Mus musculus",4,"SER A 144;ARG B 134;GLN A  88;ASP A 110","None","1.16A","1zzuB-2p24A:undetectable","1zzuB-2p24A:22.00"],["3A27_A_SAMA250_1","UNCHARACTERIZED PROTEIN MJ1557","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN","Mus musculus",3,"MET A  44;GLU A  25;ASN A 140","None","0.98A","3a27A-2p24A:undetectable","3a27A-2p24A:21.68"],["3N62_B_MTLB870_0","NITRIC OXIDE SYNTHASE","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus;Mus musculus",4,"SER A 144;ARG B 134;GLN A  88;ASP A 110","None","1.15A","3n62B-2p24A:undetectable","3n62B-2p24A:22.41"],["4B53_B_ACTB1445_0","IG GAMMA-4 CHAIN C REGION","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN","Mus musculus",3,"GLU A  25;GLY A  28;SER A   8","None","0.44A","4b53B-2p24A:15.4","4b53B-2p24A:17.99"],["4DX7_B_DM2B1104_1","ACRIFLAVINE RESISTANCE PROTEIN B","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN","Mus musculus",4,"GLN A  21;GLU A  25;ILE A 119;VAL A 165","None","0.98A","4dx7B-2p24A:undetectable","4dx7B-2p24A:14.18"],["4F8Y_B_VK3B202_1","NADPH QUINONE OXIDOREDUCTASE;NADPH QUINONE OXIDOREDUCTASE","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus",4,"ASN A  69;TYR B 147;TYR B 161;LEU B 138","None","1.39A","4f8yA-2p24A:undetectable;4f8yB-2p24A:undetectable","4f8yA-2p24A:21.57;4f8yB-2p24A:21.57"],["4FGL_C_CLQC303_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN","Mus musculus",4,"GLY A   7;VAL A   6;HIS A   5;PHE A  48","None","0.82A","4fglD-2p24A:undetectable","4fglD-2p24A:24.91"],["4J4V_D_SVRD301_1","NUCLEOCAPSID PROTEIN;NUCLEOCAPSID PROTEIN","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus",5,"GLY A 169;ASN A  84;ARG B 134;ALA A  82;ILE A 117","None","1.29A","4j4vD-2p24A:undetectable;4j4vE-2p24A:undetectable","4j4vD-2p24A:22.58;4j4vE-2p24A:22.58"],["4MWR_A_ZMRA513_2","NEURAMINIDASE","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus",4,"LEU B 175;ASP B 141;ARG B 125;ILE A   1","None","1.40A","4mwrA-2p24B:undetectable","4mwrA-2p24B:20.78"],["4YV5_A_SVRA205_1","BASIC PHOSPHOLIPASE A2 HOMOLOG 2","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN","Mus musculus",4,"ASN A 118;TYR A 150;LEU A 151;PHE A 153","None","1.25A","4yv5A-2p24A:undetectable","4yv5A-2p24A:17.50"],["4YV5_B_SVRB207_2","BASIC PHOSPHOLIPASE A2 HOMOLOG 2","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN","Mus musculus",4,"ASN A 118;TYR A 150;LEU A 151;PHE A 153","None","1.24A","4yv5B-2p24A:undetectable","4yv5B-2p24A:17.50"],["5A06_B_SORB1342_0","ALDOSE-ALDOSE OXIDOREDUCTASE","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN","Mus musculus",4,"ILE A  63;LEU A  60;GLY A  58;GLY A  59","None","0.85A","5a06B-2p24A:undetectable","5a06B-2p24A:20.58"],["5A06_F_SORF1341_0","ALDOSE-ALDOSE OXIDOREDUCTASE","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN","Mus musculus",4,"ILE A  63;LEU A  60;GLY A  58;GLY A  59","None","0.86A","5a06F-2p24A:undetectable","5a06F-2p24A:20.58"],["5DV4_A_NMYA601_2","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus",3,"GLU B 287;TRP B 288;ASN B 234","None","1.05A","5dv4A-2p24B:undetectable","5dv4A-2p24B:20.59"],["5FSA_B_X2NB590_1","CYP51 VARIANT1","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus",5,"GLY B   1;TYR A 133;PHE A 138;ILE A 106;GLY B 251","None","1.29A","5fsaB-2p24B:undetectable","5fsaB-2p24B:19.67"],["5W3J_B_TA1B502_1","TUBULIN BETA CHAIN","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U ALPHA CHAIN;H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus",4,"VAL A  72;HIS B  10;GLY B 154;LEU B 138","None","0.93A","5w3jB-2p24A:undetectable","5w3jB-2p24A:20.65"],["5YOD_F_BEZF201_0","NS3 PROTEASE","2p24","H-2 CLASS II HISTOCOMPATIBILITY ANTIGEN, A-U BETA CHAIN","Mus musculus",4,"ALA B   9;SER B   8;TYR B 167;TYR B 160","None","1.44A","5yodF-2p24B:undetectable","5yodF-2p24B:21.48"]]